Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
Vibha Jawa, Frances Terry, Jochem Gokemeijer, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Immunogenicity and humanization of single‐domain antibodies
Martín A. Rossotti, Kasandra Bélanger, Kevin A. Henry, et al.
FEBS Journal (2021) Vol. 289, Iss. 14, pp. 4304-4327
Open Access | Times Cited: 111
Assessing developability early in the discovery process for novel biologics
Monica L. Fernández‐Quintero, Anne Ljungars, Franz Waibl, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 49
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
Silvio Danese, Maria Kłopocka, Ellen Scherl, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 19, Iss. 11, pp. 2324-2332.e6
Open Access | Times Cited: 60
Strategies for clinical dose optimization of T cell-engaging therapies in oncology
Kathryn Ball, Simon J. Dovedi, Pavan Vajjah, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 38
Therapeutic proteins: developments, progress, challenges, and future perspectives
Vimal Kumar, Arti Barwal, Nitin Sharma, et al.
3 Biotech (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 9
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( Part 3 –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)
Bart Corsaro, Tong‐Yuan Yang, Rocio Murphy, et al.
Bioanalysis (2021) Vol. 13, Iss. 6, pp. 415-463
Closed Access | Times Cited: 50
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning
Emily K. Makowski, Tiexin Wang, Jennifer M. Zupancic, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 1, pp. 45-56
Closed Access | Times Cited: 21
Immunogenicity risk assessment of synthetic peptide drugs and their impurities
Anne S. De Groot, Brian Roberts, Aimee E. Mattei, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103714-103714
Open Access | Times Cited: 19
Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective
Hillel P. Cohen, Matthew Turner, Dorothy McCabe, et al.
BioDrugs (2023) Vol. 37, Iss. 5, pp. 583-593
Open Access | Times Cited: 18
The Astonishing Accomplishment of Biological Drug Delivery using Lipid Nanoparticles: An Ubiquitous Review
Devesh U. Kapoor, Shirisha C. Chilkapalli, Bhupendra G. Prajapati, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 15, pp. 1952-1968
Closed Access | Times Cited: 6
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
Aimee E. Mattei, Andres H. Gutiérrez, Soorya Seshadri, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
The Perspective of DMPK on Recombinant Adeno-Associated Virus-Based Gene Therapy: Past Learning, Current Support, and Future Contribution
Nancy Chen, Kefeng Sun, Nagendra Chemuturi, et al.
The AAPS Journal (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 24
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine
Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesæther Brun, et al.
BioDrugs (2022) Vol. 36, Iss. 6, pp. 731-748
Open Access | Times Cited: 23
Innovative epitopes in Staphylococcal Protein-A an immuno-informatics approach to combat MDR-MRSA infections
Pengjun Zhou, Xingming Shi, Jinquan Xia, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Understanding the molecular bridges between the drugs and immune cell
Umesh Chandra Dash, Vinayak Nayak, Hiten Shanker Navani, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108805-108805
Open Access
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity
Dan Qin, Qui Phung, Patrick Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Application of humanized mice in the safety experiments of antibody drugs
Zhimin Sun, Mengyun Gu, Zixuan Yang, et al.
Animal Models and Experimental Medicine (2025)
Open Access
Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights
Doni Dermawan, Nasser Alotaiq
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Design of orthogonal constant domain interfaces to aid proper heavy/light chain pairing of bispecific antibodies
Kyle A. Barlow, Michael B. Battles, Michael E. Brown, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Highly Variable Aggregation and Glycosylation Profiles and Their Roles in Immunogenicity to Protein-Based Therapeutics
Sina Sarsarshahi, Sanghati Bhattacharya, Zeb R. Zacharias, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103771-103771
Closed Access
Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches
Anne S. De Groot, Aimee E. Mattei, Benjamin Gabriel, et al.
Pharmaceutical Research (2025)
Open Access
Advances in antimicrobial peptides: From mechanistic insights to chemical modifications
Yang Ren, Xiaohan Ma, Feng Peng, et al.
Biotechnology Advances (2025), pp. 108570-108570
Open Access
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy
Guilhem Richard, Michael F. Princiotta, Dominique Bridon, et al.
Expert Review of Vaccines (2021) Vol. 21, Iss. 2, pp. 173-184
Open Access | Times Cited: 29
Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells
Sivan Cohen, Srividya Myneni, Anna R. Batt, et al.
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 23
The Shape of Nanostructures Encodes Immunomodulation of Carbohydrate Antigen and Vaccine Development
Suraj Toraskar, Preeti Chaudhary, Raghavendra Kikkeri
ACS Chemical Biology (2022) Vol. 17, Iss. 5, pp. 1122-1130
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top